COMMUNIQUÉS West-GlobeNewswire

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
20/05/2026
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum Mont-Saint-Guibert, Belgium – May 20, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext [...]
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis
20/05/2026
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis Mont-Saint-Guibert, Belgique – 20 mai 2026, [...]
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
20/05/2026
Virtual webinar to be held on Wednesday, May 27 at 11:00 AM ET LA JOLLA, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Equillium , Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe [...]
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
BOSTON and SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
20/05/2026
MIAMI, May 20, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today [...]
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
20/05/2026
Conference call and webcast to discuss results to be held on June 22, 2026 at 8 a.m. ET IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the [...]
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
20/05/2026
State-Funded Firefighter Cancer Screening Programs Expected to Drive Meaningful Revenue Growth Beginning in Q2 2026 $5.0 Million Private Placement Strengthens Cash Position to $4.2 Million as of March 31, 2026 Recent [...]
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one [...]
Cytokinetics to Hold Annual Meeting of Stockholders
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 27, 2026 at 10:00 AM Pacific [...]
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
20/05/2026
Agency takes action to combat unauthorized tobacco products resembling candy, breath strips, and cough drops Silver Spring, MD, May 20, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration announced today that [...]
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
20/05/2026
Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system disorders and [...]
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
20/05/2026
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registered direct offering priced at- [...]
Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close
20/05/2026
Alongside a national brand modernization effort, Ronald McDonald House New England is preparing to embark on a bold new chapter—one that will meaningfully expand their ability to support families navigating pediatric [...]
How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime
20/05/2026
Testo Prime Launched Safe and Natural Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Read User Guide to Best Result For Energy, Stamina and Performance New York City, May 20, 2026 (GLOBE NEWSWIRE) -- IN [...]
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
20/05/2026
agenT-797 demonstrates pathogen suppression, lung immune restoration and tissue repair activation, supporting Ongoing Phase 2 trial Sequential immunotherapy with agenT-797 and N-803, an FDA-approved IL-15 superagonist, [...]
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
20/05/2026
Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026 Shetty is IM8’s first global ambassador from [...]
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
20/05/2026
MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the commencement of its first clinical trial for an antiparasitic drug candidate powered by Gelteq ® technology, marking a [...]
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
20/05/2026
Company to Hold its Fifth Annual ‘Investor Sesh’ in Appreciation of Investor Support and in Commitment to Transparency for Shareholders LONG BEACH, Calif. and TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- Glass House Brands [...]
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
20/05/2026
31 vonoprazan-related clinical abstracts presented at Digestive Disease Week (DDW) 2026, including 28 independent analyses across GI conditions and three Phathom-sponsored clinical research abstracts Independent [...]

Pages